SUBSCRIBE
Biohealth Innovation
Founding Member of
SUBSCRIBE
Events Calendar
EIR Feedback Day - July 19
This free 1:1 virtual session is an opportunity to discuss your company with experts in diagnostics, therapeutics, digital health and medical devices.
If you’re a growth-stage biohealth company looking for unbiased advice on your pitch deck, commercialization strategy, evidence development or entrepreneurial challenges, our EIRs can help.
To request a feedback session, please send a non-confidential pitch deck, and a short description of the input you’re seeking from the EIRs, to Dr. Monique Bennett: mbennett@
The requested information should be received by our office at least 2 weeks in advance, so that we can schedule the appropriate experts. Thank you!
AgBio 2023
Virginia and North Carolina are uniting to transform the agricultural industry. We are combining strengths for an exceptional half-day conference to bring forth innovative solutions of bioscience and technology to the farms!
It is a remarkable convergence of multi-state agricultural bioscience, technology, industry partners, farmers, policy makers, agribusiness stakeholders, universities and public health.
Teaming together we multiply our opportunities and cultivate partnerships to plow forth industry success, all under one roof. Come join us!
July 19, 2023
9:30 am -2:00 pm
The Institute for Advanced Learning and Research
Danville, Virginia
If you are interested in event sponsorship, please contact Frank Wilton.
Reserve your stay at Courtyard Danville by June 18th for the best rates!
https://www.vabio.org/events/agbio/agbio2023/
EIR Feedback Day - August 16
This free 1:1 virtual session is an opportunity to discuss your company with experts in diagnostics, therapeutics, digital health and medical devices.
If you’re a growth-stage biohealth company looking for unbiased advice on your pitch deck, commercialization strategy, evidence development or entrepreneurial challenges, our EIRs can help.
To request a feedback session, please send a non-confidential pitch deck, and a short description of the input you’re seeking from the EIRs, to Dr. Monique Bennett: mbennett@
The requested information should be received by our office at least 2 weeks in advance, so that we can schedule the appropriate experts. Thank you!
Ambassadors of Buzz – Summer Sizzle
Calling all Ambassadors of Buzz (current + future)! Mix + mingle with some of our favorite people while buzzing about what’s on the horizon for BioBuzz.
Thursday, August 17 | 4-7PM
4:00pm – Networking + Tours of City Garage
5:00pm – Presentation + Q&A
6:00pm – More Networking
There is no power for change greater than a community. Join ours. If you’re passionate about life sciences, connecting others and making a difference today for a greater tomorrow, RSVP.
NCI Technology Opportunities Webinar: GPC1 as a New Therapeutic Target in Pancreatic Cancer: Development of Antibodies and CAR-T
Register to attend a free NIH webinar. Attendees will learn about a new targeted immunotherapy pancreatic cancer treatment centered on the Glypican-1 (GPC1) cell surface heparan sulfate proteoglycan protein which is overexpressed in pancreatic cancer. The webinar will be presented by Dr. Mitchell Ho, Deputy Chief, NCI Laboratory of Molecular Biology.
Webinar overview: The inventors will discuss the development of their novel Chimeric Antigen Receptors (CARs) specific for GPC1 that include short Immunoglobulin subclass 4 (IgG4) hinge sequences between the extracellular antigen recognition domain and the transmembrane domain. Hinge changes in CAR design can achieve the threshold of antigen density required for optimal CAR-T cell activity. Specifically, the optimized GPC1-IgG4 hinge CARs show rapid and complete tumor regression in mouse models.
BLUE KNIGHT™ QuickPitch: Activating for the Future
Join us at JLABS @ Washington, DC for the BLUE KNIGHT™ QuickPitch: Activating for the Future. Come listen to our selected finalists showcase their novel ideas that aim to enhance preparedness toward future known and unknown health threats.
What can you expect?
• Watch inspiring innovators pitch their novel ideas.
• Take an inside look as our panel of industry experts digs deeper into the next-generation of innovation in this space.
• Enjoy a networking lunch with entrepreneurs, scientists, funders, investors and industry experts from Johnson & Johnson, BARDA and the global preparedness community.
Space is limited, so be sure to register early to secure your spot!
This program is a product of a collaboration between Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA), part of Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services.
Opportunity for 1:1 Meetings
Companies interested in being considered for one-on-one meetings with selected judges or BLUE KNIGHT™ leadership will need to apply by August 18, 2023. Selected companies will be notified by August 25.
Application Process
1. Register for the QuickPitch Event and indicate interest in one-on-one meetings
2. Fill out the supplemental form and upload non-confidential slide deck by August 18
3. Receive notification of selection by August 25
If you have any questions, please reach out to Brennan Fournier – BFourni3@its.jnj.com.
https://blueknightquickpitch.splashthat.com/
2023 Technology Showcase
The Frederick National Laboratory Advanced Technology Research Facility in Frederick, MD, is set to host the 2023 Technology Showcase on September 6, 2023. This annual event serves as a platform for potential industry partners to engage with the National Cancer Institute (NCI) and Frederick National Laboratory (FNL).
Registration and Attendance
Interested parties can register to attend the showcase either in person or online. Each mode of attendance has its own unique registration link, offering flexibility for participants.
What to Expect
The Technology Showcase is a free hybrid event featuring a variety of activities and opportunities:
Inventor Highlights: NCI and FNL inventors will present technologies ripe for commercialization and collaboration.
Programmatic Insights: Leaders from NCI and FNL will share avenues for potential collaboration.
Partnership Perspectives: The event will provide insights into what partnering with NCI and FNL entails, including viewpoints from companies that have successfully collaborated.
Panel Sessions: These will feature success stories and topics relevant to the commercialization of biomedical technology.
Lightning Pitch Competition and Poster Session: These segments will spotlight NIH technologies available for co-development or licensing, presented by the NCI Technology Transfer Ambassadors Program.
Who Should Attend?
The event is an excellent opportunity for companies, investors, entrepreneurs, technology scouts, and all stakeholders in the biotech industry to discover technologies ready for commercialization.
Networking Opportunities
The showcase will conclude with an independently sponsored networking event nearby, allowing attendees to connect and discuss potential collaborations further.
Location
For those attending in person, the event will be held at the FNL Advanced Technology Research Facility, located at 8560 Progress Drive, Frederick, MD 21701.
Don't miss this chance to be part of an event that could shape the future of biotechnology and healthcare. Sign up now to receive email updates about this exciting event.
For more information and to register, visit the https://techtransfer.cancer.gov/news-events/events-webinars/2023-technology-showcase.
Announcing Session 2 of THL23: "Opportunities and Challenges for Preempting Chronic Diseases before They Start"
Announcing Session 2 of the Targeting Healthy Longevity 2023 conference, a free webinar on Opportunities and Challenges for Preempting Chronic Diseases before They Start, on Wednesday, September 13, 2023, from 11 a.m. to 12:30 p.m. EDT.
Healthcare has traditionally focused on ‘disease care,’ but science increasingly allows us to observe and understand deviations at molecular and cellular levels that can predict the onset of diseases, in some cases years later. Developing interventions in the pre-disease state will be key to extending healthspan and economic solvency of the healthcare system. However, regulatory and reimbursement focus on demonstration of clinical benefit is not well-equipped for the transition from disease treatment to disease prevention.
Please join moderator George Vradenburg, founder of UsAgainstAlzheimers and the Davos Alzheimer’s Collaborative, and a stellar roundtable of thought leaders including:
Lord Ara Darzi, Director of the Institute of Global Health Innovation at Imperial College London and head of Flagship Pioneering’s Preemptive Health and Medicine Initiative
Hilary Evans, Chief Executive of Alzheimer’s Research UK, a member of the World Dementia Council and co-chair of the UK government’s national dementia initiative
Mark McClellan, former FDA Commissioner and former CMS Administrator
Dame June Raine, Chief Executive of UK MHRA
David Ricks, CEO of Eli Lilly
Samantha Roberts, Chief Executive of UK NICE
Register HERE for a can’t miss conference session on one of the most important healthcare challenges and opportunities of this century: the transition from disease treatment to prevention.
About Targeting Healthy Longevity:
Targeting Healthy Longevity (previously called Targeting Metabesity) is an acclaimed annual conference organized by the not-for-profit Kitalys Institute, with its mission of accelerating the translation of science into public health to prevent chronic diseases and extend healthy longevity. Since its inaugural event in London in 2017, the conference has assembled top leaders in geroscience and chronic diseases; members of Congress and the UK Parliament; public health agencies such as NIH and FDA; Big Pharma, Big Food and Big Data and corresponding emerging companies; capital markets; and other stakeholders for silo-busting discussions on natural and social science, medicine and public policy.
The inaugural session of Targeting Healthy Longevity 2023 (THL23) was a virtual fireside chat with FDA Commissioner Rob Califf on May 3, 2023 on regulation of healthspan products, see www.kitalys.org. Other sessions planned for THL23 later this fall include Loneliness: A Risk Factor Bigger than Smoking or Obesity? moderated by Lucy Rose, founder of The Cost of Loneliness Project, and Jeremy Abbatte, Publisher of Scientific American, and a two-part session on the 21,000+ subject COSMOS, COSMOS-Mind and COSMOS-Web Trials, which have yielded learnings from large prospective randomized controlled trials on the cardiovascular and mental health benefits of nutritional supplements such as flavanols and vitamins.
Developing Preemptive Interventions in the Pre-Disease State
Announcing Session 2 of the Kitalys Institute's Targeting Healthy Longevity 2023 rolling conference: a free webinar on Developing Preemptive Interventions in the Pre-Disease State, on Wednesday, September 13, 2023, from 11 a.m. to 12:30 p.m. EDT.
Healthcare has traditionally focused on ‘disease care,’ but science increasingly allows us to observe and understand deviations at molecular and cellular levels that can predict the onset of diseases, in some cases years later. Developing interventions in the pre-disease state will be key to extending healthspan and economic solvency of the healthcare system. However, regulatory and reimbursement focus on demonstration of clinical benefit is not well-equipped for the transition from disease treatment to disease prevention.
Please join moderator George Vradenburg, founder of UsAgainstAlzheimers and the Davos Alzheimer’s Collaborative, and a stellar roundtable of thought leaders including:
Lord Ara Darzi, head of Flagship Pioneering’s Preemptive Medicine and Health Initiative
Mark McClellan, MD, PhD, former FDA Commissioner and former CMS Administrator
David Ricks, CEO of Elil Lilly
Dr. Samantha Roberts, CEO of UK NICE
The State of Biotech 2023
Despite the tough market conditions for the industry over the past 2–3 years, the biotechnology sector is poised for big things moving forward. Exciting advances in precision genome editing, cell therapy, synthetic biology, organs-on-chips, next-gen sequencing and artificial intelligence all bode well for the development of new therapies and the health of patients and the industry.
In The State of Biotech 2023–sponsored exclusively by Cytiva–GEN proudly brings together a host of luminaries from industry and academia to discuss the latest research developments, innovations and disruptive technologies that will spur biotech forward to bigger and better things.
Please join us on September 13 for an exciting program featuring:
- Opening keynote conversation with 2022 Nobel laureate Carolyn Bertozzi, PhD
- A keynote presentation from David Baker, PhD (University of Washington/HHMI)
- Panel discussions on the state of CRISPR/genome editing and cell therapy
- Roundtables on the state of synbio and mRNA therapeutics
- A conversation on biotech business trends with the four co-hosts of the popular Biotech Hangout show
- Breakout sessions and much more
The State of Biotech 2023 is GEN’s flagship virtual event, following its successful introduction in 2022. Registration is entirely free.
https://webinars.liebertpub.com/e/the-state-of-biotech-2023?aff=100